WO2026013547 - USE OF 5-METHOXY-2-AMINOINDAN ("MEAI") IN METHODS FOR WEIGHT LOSS AND TREATING FATTY LIVER DISEASE
National phase entry is expected:
Publication Number
WO/2026/013547
Publication Date
15.01.2026
International Application No.
PCT/IB2025/056865
International Filing Date
08.07.2025
Title **
[English]
USE OF 5-METHOXY-2-AMINOINDAN ("MEAI") IN METHODS FOR WEIGHT LOSS AND TREATING FATTY LIVER DISEASE
[French]
UTILISATION DE 5-MÉTHOXY-2-AMINOINDANE ("MEAI") DANS DES MÉTHODES DE PERTE DE POIDS ET DE TRAITEMENT D'UNE STÉATOSE HÉPATIQUE
Applicants **
CLEARMIND LABS CORP.
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
Inventors
ZULOFF-SHANI, Adi
BARAGHITHY, Saja
TAM, Joseph
Priority Data
63/668,632
08.07.2024
US
63/671,385
15.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5490 | |
| EPO | Filing, Examination, Granting | 102728 | |
| Japan | Filing, Examination, Granting | 4866 | |
| South Korea | Filing, Examination, Granting | 7786 | |
| USA | Filing, Examination, Granting | 22790 |
Total:
143,660
Contact Us
Abstract[English]
The disclosure relates to methods for losing weight by administering a therapeutically effective amount of 5-methoxy-2-aminoindan or a pharmaceutically acceptable salt thereof to a subject in need thereof for a period of time sufficient to increase basal energy expenditure. The disclosure also relates to methods for treating fatty liver disease by administering a therapeutically effective amount of 5-methoxy-2-aminoindan or a pharmaceutically acceptable salt thereof to a subject in need thereof.[French]
L'invention concerne des méthodes de perte de poids par administration d'une quantité thérapeutiquement efficace de 5-méthoxy-2-aminoindane ou d'un sel pharmaceutiquement acceptable de celui-ci à un sujet en ayant besoin pendant une période de temps suffisante pour augmenter la dépense énergétique basale. L'invention concerne également des méthodes de traitement d'une stéatose hépatique par administration d'une quantité thérapeutiquement efficace de 5-méthoxy-2-aminoindane ou d'un sel pharmaceutiquement acceptable de celui-ci à un sujet en ayant besoin.